Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the expansion of structural heart and neurovascular product portfolios, the Chairman & Chief Executive Officer ensures alignment between research initiatives and global market demands. This leadership role involves managing high-level relationships with stakeholders and guiding the company through complex regulatory landscapes across international markets. By prioritizing innovation in aortic and mitral valve technologies, Michael Zhang directly impacts the company's ability to provide accessible medical solutions to hospitals worldwide. Through rigorous oversight of corporate governance and strategic resource allocation, Zhang secures the competitive positioning of the firm within the high-end medical device sector. The Chairman & Chief Executive Officer maintains a focus on sustainable growth while fostering a culture of clinical excellence and patient-centric development across all operational divisions.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages the fiscal health and capital allocation strategies necessary for sustained innovation in medical device manufacturing. Overseeing financial planning, reporting, and investor relations, the Chief Financial Officer ensures the company maintains the liquidity required to fund complex neurovascular and structural heart research projects. This leadership role involves optimizing cost structures and evaluating investment opportunities to support the firm's global expansion efforts. By implementing robust financial controls and risk management frameworks, Leo Tsai directly impacts the stability and growth trajectory of the organization. Through collaboration with the executive team, Tsai aligns budgetary priorities with the long-term mission of delivering high-end medical solutions to healthcare providers. The Chief Financial Officer drives transparency and accountability, ensuring that financial performance consistently supports the strategic objectives of the company in the competitive medical technology landscape.

Karl Pan, the Chief Operating Officer at Peijia Medical, directs the daily operational activities and supply chain logistics required to manufacture high-end medical devices. Overseeing production efficiency, quality assurance, and regional distribution networks, the Chief Operating Officer ensures that the company meets the rigorous demands of hospitals and healthcare providers dealing with cardiovascular diseases. This leadership role involves streamlining internal processes to enhance manufacturing throughput and maintaining compliance with international medical device standards. By optimizing operational workflows, Karl Pan directly impacts the company's ability to deliver consistent, high-quality products across diverse geographic markets. Through close coordination with the executive team, Pan aligns operational capacity with the strategic growth goals of the firm. The Chief Operating Officer maintains a focus on operational excellence and resource management, ensuring that the supply chain remains resilient and capable of supporting the company's mission to improve patient quality of life.

JianFong Tan, the Chief Technology Officer at Peijia Medical, architects the research and development roadmap for advanced structural heart and neurovascular intervention products. Overseeing the engineering teams and clinical innovation pipelines, the Chief Technology Officer ensures the delivery of safe, effective, and cutting-edge medical devices to the global market. This leadership role involves bridging the gap between complex engineering challenges and practical clinical applications for aortic, mitral, and tricuspid valve solutions. By fostering a culture of continuous technical improvement, JianFong Tan directly impacts the company's ability to maintain a competitive edge in the medical device industry. Through strategic partnerships with research institutions and internal development teams, Tan accelerates the transition of prototypes into life-saving commercial products. The Chief Technology Officer maintains a focus on technical scalability and product reliability, ensuring that every innovation meets the highest standards of quality for healthcare providers and patients.